MoneyWorks4Me

Lasa Supergenerics - Quaterly Results

09 Jun 2023 Evaluate
The sales for the March 2023 quarter moved down -31.03% to Rs. 353.23 millions as compared to Rs. 512.12 millions during the year ago period.The Net Loss for the quarter ended March 2023 is Rs. -150.03 millions as compared to Net Profit of Rs. 121.29 millions of corresponding quarter ended March 2022The company reported a degrowth in operating Profit to 52.70 millions from 109.45 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 353.23 512.12 -31.03 1295.68 1371.27 -5.51 1295.68 1371.27 -5.51
Other Income 9.31 1.96 375.00 18.05 2.75 556.36 18.05 2.75 556.36
PBIDT 52.70 109.45 -51.85 -47.89 162.72 -129.43 -47.89 162.72 -129.43
Interest 4.15 0.07 5828.57 41.61 0.40 10302.50 41.61 0.40 10302.50
PBDT -150.42 149.81 -200.41 -288.47 83.72 -444.57 -288.47 83.72 -444.57
Depreciation 41.70 36.11 15.48 134.19 145.11 -7.53 134.19 145.11 -7.53
PBT -192.12 113.70 -268.97 -422.66 -61.39 588.48 -422.66 -61.39 588.48
TAX -42.09 -7.59 454.55 -36.45 -8.07 351.67 -36.45 -8.07 351.67
Deferred Tax -42.09 -9.86 326.88 -36.88 -14.55 153.47 -36.88 -14.55 153.47
PAT -150.03 121.29 -223.70 -386.21 -53.32 624.32 -386.21 -53.32 624.32
Equity 501.01 406.73 23.18 501.01 406.73 23.18 501.01 406.73 23.18
PBIDTM(%) 14.92 21.37 -30.19 -3.70 11.87 -131.15 -3.70 11.87 -131.15
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..